Uv protectant formulations
US-2024074949-A1 · Mar 7, 2024 · US
US9616001B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9616001-B2 |
| Application number | US-201414775020-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 14, 2014 |
| Priority date | Mar 15, 2013 |
| Publication date | Apr 11, 2017 |
| Grant date | Apr 11, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to new (foodgrade) solid lipid nanoparticles, as well as the production of such solid lipid nanoparticles and the use of them.
Opening claim text (preview).
The invention claimed is: 1. Solid lipid nanoparticles comprising (a) a core comprising, (a1) a lipid phase in a solid state, and (a2) up to 60 wt-%, based on the total weight of the solid lipid nanoparticles, of at least one lipophilic and/or amphiphilic active ingredient, and (b) an emulsifier system comprising: (b1) at least one emulsifier; (b2) 0.1-30 wt-%, based on the total weight of the solid lipid nanoparticles, of at least one co-emulsifier selected from the group consisting of polysorbates, phospholipids, stearoyl-2-lactylat and citric ester of mono and di-glycerides, and (b3) 0.1-30 wt. %, based on the total weight of the solid lipid nanoparticles, of at least one saponin compound, wherein the solid lipid nanoparticles are substantially spherical with a diameter of 50-300 nm. 2. The solid lipid nanoparticles according to claim 1 , wherein the emulsifier system has a crystallization point which is lower than a crystallization point of the core. 3. The solid lipid nanoparticles according to claim 1 , wherein the lipid phase is at least one oil selected from the group consisting of triglycerides, partial glycerides, fatty acids, steroids and waxes. 4. The solid lipid nanoparticles according to claim 1 , wherein the lipophilic and/or amphiphilic active ingredient is selected from the group consisting of antimicrobials, antioxidants, polyphenols, vitamins, polyunsaturated fatty acids (PUFAs) and dyestuffs. 5. The solid lipid nanoparticles according to claim 1 , wherein the saponin is Quillaia saponaria. 6. The solid lipid nanoparticles according to claim 1 wherein the at least one saponin is present in a concentration of 0.5-20 wt-%, based on the total weight of the solid lipid nanoparticles. 7. The solid lipid nanoparticles according to claim 1 , wherein the at least one co-emulsifier is present in a concentration of 0.5-20 wt-%, based on the total weight of the solid lipid nanoparticles. 8. A food product, feed product or personal care product comprising the solid lipid nanoparticles as claimed in claim 1 .
Magnoliopsida [dicotyledons] · CPC title
Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal · CPC title
General cosmetic use · CPC title
Encapsulation of particles, e.g. foodstuff additives · CPC title
Stabilizers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.